Nanoparticle albumin-bound (nab)-technology is a new technology for anti-cancer drug delivery system that has been developed by American Bioscience, Inc. Albumin particles with paclitaxel (nab-paclitaxel, 100–200 nm) have been approved in 2006 for use in patients with metastatic breast cancer due to their superior antitumor efficacy over paclitaxel [43]. Here, ALB is linked to cancer.